Clinical Trial Update: A Prospective Trial of Dalbavancin-Based Prophylaxis in Children and Adolescents With High-Risk Leukemia [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating dalbavancin-based prophylaxis in children and adolescents with high-risk leukemia; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia

Drugs mentioned

• Dalvance (dalbavancin)

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Leukemia, Acute Myeloid Leukemia | Phase 1 | Status: RECRUITING